BERLIN (Reuters) - German pharmaceuticals group Bayer keeps benefiting from the weak euro, though the region's deepening debt crisis is beginning to weigh on orders in some sectors, a Swiss newspaper reported, citing the group's chief financial officer.
via Reuters: Health News Read More Here..
No comments:
Post a Comment